Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients
- 27 October 2015
- journal article
- Published by Springer Nature in Neurological Sciences
- Vol. 37 (2) , 261-267
Abstract
Multiple sclerosis (MS) is an auto-immune disease whose etiology remains controversial. Both genetic and environmental factors are thought to be involved in the risk of developing the disease. The purpose of our study was to assess the association of Vitamin D receptor (VDR) polymorphisms with MS and to investigate the interaction of these polymorphisms with vitamin D levels. A total of 179 Sicilian subjects, including 104 MS patients and 75 healthy controls, were studied. The most common VDR polymorphisms (Fok-I, Bsm-I, Taq-I and Apa-I) were genotyped by polymerase chain reaction (PCR) followed by restriction fragment length polymorphism (RFLP) analyses in both groups and serum 25-hydroxyvitamin D [25(OH)D] levels were determined in MS patients by high-performance liquid chromatography (HPLC). The distribution of genotype and allele frequencies of the four VDR polymorphisms did not differ significantly between MS patients and healthy controls, and were unrelated to the forms and the course of MS. Low serum levels of 25(OH)D were observed in MS patients but no association was observed between VDR and 25(OH)D levels except for Fok-I. Moreover, MS patients with FF and Ff genotype had a significantly lower serum levels of 25(OH)D compared with ff carriers (P < 0.05 FF vs Ff and Ff vs ff). Our findings showed no association between VDR polymorphisms and risk of MS. Interestingly, F allele could confer a genetic predisposition to lower 25(OH)D levels.Keywords
This publication has 36 references indexed in Scilit:
- Vitamin D3 Receptor (VDR) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-AnalysisPLOS ONE, 2013
- Vitamin D in Systemic and Organ-Specific Autoimmune DiseasesClinical Reviews in Allergy & Immunology, 2012
- A Randomized Trial of High-Dose Vitamin D2 in Relapsing-remitting Multiple SclerosisNeurology, 2012
- A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosisNature, 2011
- Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest GreeceJournal of Negative Results in BioMedicine, 2011
- Common genetic determinants of vitamin D insufficiency: a genome-wide association studyThe Lancet, 2010
- Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosisMultiple Sclerosis Journal, 2009
- Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosisJournal of Neuroimmunology, 2009
- PAST SUN EXPOSURE, SKIN PHENOTYPE AND RISK OF MULTIPLE SCLEROSISEpidemiology, 2003